COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

Background: To determine the effect of disease-modifying therapies (DMT) on humoral postvaccine seroconversion, long-term humoral response, and breakthrough COVID-19 infections in persons with multiple sclerosis (PwMS) and other neuroinflammatory disorders. Methods: A total of 757 PwMS and other neu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dejan Jakimovski, Karen Zakalik, Samreen Awan, Katelyn S. Kavak, Penny Pennington, David Hojnacki, Channa Kolb, Alexis A. Lizarraga, Svetlana P. Eckert, Rosila Sarrosa, Kamath Vineetha, Keith Edwards, Bianca Weinstock-Guttman
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-04-01
coleção:	Vaccines
Assuntos:	COVID-19 SARS-CoV-2 vaccination BNT162b2 mRNA-1273 Ad26.COV2.S breakthrough infection
Acesso em linha:	https://www.mdpi.com/2076-393X/10/5/695
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!